Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
45.97
+1.79 (4.05%)
Mar 4, 2026, 3:28 PM EST - Market open

Maze Therapeutics Stock Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for Maze Therapeutics stock have an average target of 48.67, with a low estimate of 36 and a high estimate of 60. The average target predicts an increase of 5.87% from the current stock price of 45.97.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $36 $48.67 $55 $60
Change -21.69% +5.87% +19.64% +30.52%

Analyst Ratings

The average analyst rating for Maze Therapeutics stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Oct '25Nov '25Dec '25Jan '26Feb '26Mar '26
Strong Buy 333333
Buy 334443
Hold 000000
Sell 000000
Strong Sell 000000
Total 667776

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Guggenheim
Guggenheim
Strong Buy
Maintains
$46$58
Strong Buy Maintains $46$58 +26.17% Mar 4, 2026
BTIG
BTIG
Strong Buy
Maintains
$37$46
Strong Buy Maintains $37$46 +0.07% Jan 16, 2026
Wells Fargo
Wells Fargo
Buy
Initiates
$55
Buy Initiates $55 +19.64% Dec 4, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$50$60
Strong Buy Maintains $50$60 +30.52% Dec 3, 2025
Wedbush
Wedbush
Buy
Maintains
$35$36
Buy Maintains $35$36 -21.69% Nov 7, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 167.50M
Revenue Next Year
1.36M
EPS This Year
-3.19
from 1.25
EPS Next Year
-3.20
from -3.19
Fiscal Year FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027 FY 2028
Period Ending Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027 Dec 31, 2028
Revenue
--167.50M-1.36M3.25M46.95M
Revenue Growth
-----139.04%1,344.14%
EPS
-57.18-43.891.25-3.19-3.20-3.47-2.62
EPS Growth
-------
Forward PE
-------
No. Analysts ---1211104
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027202820292030
High n/a 12.6M
Avg n/a 1.4M
Low n/a n/a

Revenue Growth

Revenue Growth 202520262027202820292030
High - -
Avg - -
Low - -

EPS Forecast

EPS 202520262027202820292030
High -2.73 -2.88
Avg -3.19 -3.20
Low -3.28 -3.96

EPS Growth

EPS Growth 202520262027202820292030
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.